1. Home

Ozempic: DH recommends alternative diabetes drugs as shortages persist

 
• By James Stent

The DH has said that patients with type two diabetes can be initiated on or switched to alternative treatments amid ongoing shortages of semaglutide and other GLP-1 RAs.

Semaglutide injection
Victoza (liraglutide) is out of stock until the end of 2024
James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

More from Clinical